Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Combining the cholesterol-lowering drugs with the diabetes drug metformin may be even better.
Genitourinary Cancers Symposium reaches beyond the latest prostate, bladder and kidney cancer treatments.
New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics.
Jill Cadman is a former patient advocate and educator living with HIV and Stage IV colon cancer.
A triple regimen of Opdivo, Yervoy and Cabometyx showed good antitumor activity, but severe side effects were common.
Love prevails when a couple’s world is upended by a breast cancer diagnosis.
Nearly 50 existing non-cancer drugs were found to kill some cancer cell lines in the lab.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
SU2C Health Equity Initiative aims to reduce racial and ethnic disparities in cancer research and improve outcomes for minority populations.
Study shows that differences in cells’ ability to turn genes into proteins change how mutations manifest; offers insights into disease risk.
Men who took Zytiga had higher quality of life scores and less pain than those treated with chemotherapy.
Discussing details about symptoms can help come up with targeted suggestions.
MK-6482 shrank tumors in 24% of people with advanced renal cell carcinoma.
The personalized vaccine was associated with a 45% lower risk of death in a real-world study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.